Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Replication protein A 70 kDa subunit N-terminal domain (RPA70N) is a critical protein-interaction module within the largest subunit (RPA1) of the heterotrimeric Replication Protein A (RPA) complex (UniProt: P27694) [1]. RPA is the primary eukaryotic single-stranded DNA (ssDNA) binding protein, essential for DNA replication, recombination, and repair. The RPA70N domain specifically utilizes an oligonucleotide/oligosaccharide-binding (OB) fold to act as a scaffold, recruiting various DNA damage response (DDR) proteins such as ATRIP, p53, and RAD9 to sites of DNA damage [2]. Because of its central role in coordinating repair pathways, RPA70N has emerged as a significant therapeutic target in oncology. Small molecule inhibitors, such as TDRL-505, target the RPA70N domain to block these protein-protein interactions, thereby sensitizing cancer cells to chemotherapy and radiotherapy by preventing effective DNA repair [3]. Research indicates that disrupting RPA70N function can lead to increased genomic instability and apoptosis in tumor cells, particularly in those with existing DDR deficiencies [2].
Inhibition of protein-protein interactions (PPI) between the RPA70N domain and DNA damage response proteins (e.g., ATRIP, p53, RAD9) to disrupt DNA repair signaling and sensitize cells to DNA-damaging agents [2, 3].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Replication protein A 70 kDa subunit N-terminal domain (RPA70N).